Spots Global Cancer Trial Database for A Study To Assess The Safety And Efficacy Of SU11248 In Patients With Gastrointestinal Stromal Tumor(GIST)
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study To Assess The Safety And Efficacy Of SU11248 In Patients With Gastrointestinal Stromal Tumor(GIST)
Official Title: A Phase III, Randomized, Double-Blind, Placebo-Controlled Study Of SU011248 In The Treatment Of Patients With Imatinib Mesylate (Gleevec Tm, Glivec)-Resistant Or Intolerant Malignant Gastrointestinal Stromal Tumor
Study ID: NCT00075218
Conditions
Study Description
Brief Summary: A study to assess the safety and efficacy of SU11248 in patients with gastrointestinal stromal tumor (GIST) whose disease has failed imatinib therapy or who were intolerant to imatinib treatment.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Pfizer Investigational Site, Duarte, California, United States
Pfizer Investigational Site, Los Angeles, California, United States
Pfizer Investigational Site, Los Angeles, California, United States
Pfizer Investigational Site, Pasadena, California, United States
Pfizer Investigational Site, Santa Monica, California, United States
Pfizer Investigational Site, Stanford, California, United States
Pfizer Investigational Site, Washington, District of Columbia, United States
Pfizer Investigational Site, Miami, Florida, United States
Pfizer Investigational Site, Tampa, Florida, United States
Pfizer Investigational Site, Park Ridge, Illinois, United States
Pfizer Investigational Site, Boston, Massachusetts, United States
Pfizer Investigational Site, Detroit, Michigan, United States
Pfizer Investigational Site, Minneapolis, Minnesota, United States
Pfizer Investigational Site, St. Louis, Missouri, United States
Pfizer Investigational Site, New York, New York, United States
Pfizer Investigational Site, New York, New York, United States
Pfizer Investigational Site, New York, New York, United States
Pfizer Investigational Site, Durham, North Carolina, United States
Pfizer Investigational Site, Cleveland, Ohio, United States
Pfizer Investigational Site, Columbus, Ohio, United States
Pfizer Investigational Site, Columubs, Ohio, United States
Pfizer Investigational Site, Portland, Oregon, United States
Pfizer Investigational Site, Philadelphia, Pennsylvania, United States
Pfizer Investigational Site, Nashville, Tennessee, United States
Pfizer Investigational Site, Seattle, Washington, United States
Pfizer Investigational Site, Seattle, Washington, United States
Pfizer Investigational Site, Madison, Wisconsin, United States
Pfizer Investigational Site, Garran, Australian Capital Territory, Australia
Pfizer Investigational Site, Camperdown, New South Wales, Australia
Pfizer Investigational Site, Randwick, New South Wales, Australia
Pfizer Investigational Site, Auchenflower, Queensland, Australia
Pfizer Investigational Site, Ashford, South Australia, Australia
Pfizer Investigational Site, Bedford Park, South Australia, Australia
Pfizer Investigational Site, East Melbourne, Victoria, Australia
Pfizer Investigational Site, Leuven, , Belgium
Pfizer Investigational Site, Toronto, Ontario, Canada
Pfizer Investigational Site, Montreal, Quebec, Canada
Pfizer Investigational Site, Lyon, , France
Pfizer Investigational Site, Marseille, , France
Pfizer Investigational Site, VILLEJUIF Cedex, , France
Pfizer Investigational Site, Aviano, PN, Italy
Pfizer Investigational Site, Candiolo, Torino, Italy
Pfizer Investigational Site, Bologna, , Italy
Pfizer Investigational Site, Genova, , Italy
Pfizer Investigational Site, Milano, , Italy
Pfizer Investigational Site, Milano, , Italy
Pfizer Investigational Site, Milano, , Italy
Pfizer Investigational Site, Torino, , Italy
Pfizer Investigational Site, Groningen, Gr, Netherlands
Pfizer Investigational Site, Rotterdam, ZH, Netherlands
Pfizer Investigational Site, Singapore, , Singapore
Pfizer Investigational Site, Singapore, , Singapore
Pfizer Investigational Site, Singapore, , Singapore
Pfizer Investigational Site, L'Hospitalet del Llobregat, Barcelona, Spain
Pfizer Investigational Site, Barcelona, , Spain
Pfizer Investigational Site, Madrid, , Spain
Pfizer Investigational Site, Lausanne, , Switzerland
Pfizer Investigational Site, Sutton, Surrey, United Kingdom
Pfizer Investigational Site, Leeds, , United Kingdom
Pfizer Investigational Site, London, , United Kingdom
Pfizer Investigational Site, Newcastle-Upon-Tyne, , United Kingdom
Contact Details
Name: Pfizer CT.gov Call Center
Affiliation: Pfizer
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
